Handelsbanken Fonder Ab Dexcom Inc Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Dexcom Inc stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 164,463 shares of DXCM stock, worth $12.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

164,463

Previous 430,140 61.77%

Holding current value

$12.4 Million

Previous $48.8 Million 77.39%

% of portfolio

0.04%

Previous 0.21%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$64.0 - $116.06 $17 Million - $30.8 Million	-265,677 Reduced 61.77%	164,463 $11 Million
Q2 2024 Aug 05, 2024	SELL	$110.31 - $140.45 $2.33 Million - $2.96 Million	-21,110 Reduced 4.68%	430,140 $48.8 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $1.29 Million - $1.58 Million	11,259 Added 2.56%	451,250 $62.6 Million
Q4 2023 Feb 01, 2024	SELL	$75.49 - $124.16 $1.86 Million - $3.06 Million	-24,615 Reduced 5.3%	439,991 $54.6 Million
Q3 2023 Oct 19, 2023	BUY	$86.06 - $137.93 $3.94 Million - $6.31 Million	45,735 Added 10.92%	464,606 $43.3 Million
Q2 2023 Aug 02, 2023	BUY	$112.47 - $130.98 $5.06 Million - $5.89 Million	45,001 Added 12.04%	418,871 $53.8 Million
Q1 2023 Apr 28, 2023	SELL	$104.0 - $122.92 $2.6 Million - $3.07 Million	-24,983 Reduced 6.26%	373,870 $43.4 Million
Q4 2022 Feb 07, 2023	BUY	$84.98 - $122.67 $1.65 Million - $2.38 Million	19,431 Added 5.12%	398,853 $45.2 Million
Q3 2022 Oct 27, 2022	BUY	$76.35 - $94.18 $531,243 - $655,304	6,958 Added 1.87%	379,422 $30.6 Million
Q2 2022 Aug 03, 2022	BUY	$67.99 - $132.89 $21 Million - $41.1 Million	309,155 Added 488.33%	372,464 $27.8 Million
Q1 2022 May 11, 2022	SELL	$94.08 - $130.2 $949,079 - $1.31 Million	-10,088 Reduced 13.74%	63,309 $32.4 Million
Q4 2021 Feb 08, 2022	SELL	$129.87 - $162.82 $1.72 Million - $2.16 Million	-13,255 Reduced 15.3%	73,397 $39.4 Million
Q3 2021 Nov 10, 2021	BUY	$106.71 - $143.18 $479,981 - $644,023	4,498 Added 5.48%	86,652 $47.4 Million
Q2 2021 Aug 03, 2021	BUY	$80.99 - $107.93 $342,182 - $456,004	4,225 Added 5.42%	82,154 $35.1 Million
Q1 2021 Apr 29, 2021	BUY	$84.79 - $104.74 $104,122 - $128,620	1,228 Added 1.6%	77,929 $28 Million
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $1.44 Million - $1.94 Million	18,518 Added 31.83%	76,701 $28.4 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $515,754 - $609,930	5,400 Added 10.23%	58,183 $24 Million
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $1.87 Million - $3.14 Million	29,783 Added 129.49%	52,783 $21.4 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $292,960 - $458,320	8,000 Added 53.33%	23,000 $5.03 Million
Q3 2019 Oct 31, 2019	BUY	$35.53 - $43.8 $532,950 - $657,000	15,000 New	15,000 $2.24 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Dexcom Inc Transaction History